Applied Therapeutics Inc.

NASDAQ: APLT · Real-Time Price · USD
0.39
0.02 (5.63%)
At close: Jun 09, 2025, 3:59 PM

Applied Therapeutics Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023
Research and Development Services Revenue 455K 774K
Research and Development Services Revenue Growth -41.21% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selling, General, and Administrative Revenue 17.69M 21.25M 15.04M 10.46M 9.07M 5.04M 4.71M 5.29M 5.58M 6.88M 6.24M 6.13M 8.07M 11.39M 10.83M 11.07M 9.75M 9.93M 10.02M 7.52M 5.2M 3.9M 3.29M 4.18M 1.85M 629K 598K 400K 420K
Selling, General, and Administrative Revenue Growth -16.75% +41.30% +43.78% +15.35% +79.95% +6.96% -11.01% -5.19% -18.85% +10.26% +1.88% -24.11% -29.14% +5.14% -2.17% +13.56% -1.83% -0.87% +33.23% +44.75% +33.20% +18.43% -21.25% +125.50% +194.91% +5.18% +49.50% -4.76% n/a
Research and Development Revenue 7.84M 11.7M 14.83M 10M 190K 15.3M 10.79M 11.88M 15.94M 12.09M 13.12M 15.4M 15.03M 15.72M 17.6M 14.8M 14.45M 13.81M 19.95M 20.76M 7.27M 13.77M 7.45M 4.25M 6.87M 5.36M 2.73M 1.94M 1.45M
Research and Development Revenue Growth -32.99% -21.13% +48.22% +5165.26% -98.76% +41.89% -9.24% -25.43% +31.78% -7.81% -14.81% +2.44% -4.41% -10.64% +18.88% +2.45% +4.59% -30.74% -3.92% +185.49% -47.19% +84.73% +75.20% -38.11% +28.25% +96.63% +40.73% +33.77% n/a